Ramp is building the world's first finance automation platform designed to save businesses time and money. Ramp offers 5-in-1 software that consolidates corporate cards, expense management, bill payments, accounting, and reporting into one simple and free solution. More than 5,000 businesses are using Ramp, from some of the fastest growing startups and unicorns like Ro, Faire, Marqeta, ClickUp, and Applied Intuition, to established businesses across the US including Bristol Hospice, Walther Farms, Douglas Elliman, and Planned Parenthood. Founded in 2019, Ramp is NYC's fastest growing startup, having achieved a unicorn valuation of $3.9 billion in just over 2 years. Ramp has raised $620 million in funding from investors including Founders Fund, Stripe, Goldman Sachs, Coatue Management, D1 Capital Partners, Redpoint Venture, Thrive Capital, Altimeter, Iconiq, Spark Capital, and the Box Group, as well as over 100 angel investors who were founders or executives of leading companies. Ramp is part of the Forbes Fintech 50, LinkedIn Top Startups of 2021, and Fast Company's Best Workplaces for Innovators program.

Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapies that are capable of making sophisticated decisions, they sought to apply the concept of the emerging field of mRNA therapeutics. This area was untapped by traditional synthetic biology, which led them to build their own mRNA “programming language,” creating the world's first platform for mRNA smart therapies. Strand's mRNA programming technology promises to make mRNA therapies safer and more effective by programming the location, timing, and intensity of therapeutic protein expression inside a patient's body using mRNA-encoded logic circuits. These circuits can implement cell-type specific expression by sensing and classifying the unique miRNA expression signatures of cells, as well as controlling the dosage of protein expression by responding to exogenously administered small molecules.